Clinical trial Recruiting at 1 site Interventional Ages 35 to 65

Shock wave therapy to reduce wrist muscle spasticity after stroke

Official title: Clinical and Ultrasonographic Evaluation of the Efficacy of Extracorporeal Shock Wave Therapy (ESWT) in Post-Stroke Spasticity: A Randomized Controlled Trial

Run by Pamukkale University · NCT07119801 · Data updated 2026-11-12

This trial will try radial extracorporeal shock wave therapy to reduce wrist flexor spasticity in adults 35–65 who had a single stroke more than six months ago.

Quick facts

Study typeInterventional
Ages35 Years to 65 Years
SexAll
Enrollment32 (estimated)
SponsorPamukkale University
Academic / other
Locations1 site (Denizli)
StatusRecruiting
StartedSeptember 5, 2025
Main results expectedApril 20, 2026
Study endsDecember 20, 2026
Registry record updatedAugust 25, 2026
Trial IDNCT07119801 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 35–65, more than six months after a first-ever stroke, with wrist flexor spasticity rated MAS 1–3 and no contraindications to ESWT.

Probably not a fit

Patients with fixed wrist contractures, severe communication problems, multiple prior strokes, recent botulinum toxin/phenol injections, significant unstable medical conditions, or contraindications to ESWT are unlikely to benefit or to be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Chronic stroke patients with moderate wrist flexor spasticity will receive radial extracorporeal shock wave therapy in addition to conventional rehabilitation, and outcomes will be compared over short-term follow-up. Clinical spasticity will be measured with the Modified Ashworth Scale while ultrasound strain elastography and echogenicity will provide objective measures of muscle stiffness and tissue quality. The protocol excludes patients with fixed contractures, recent botulinum toxin or phenol injections, multiple strokes, or medical contraindications to ESWT. The study aims to correlate clinical changes with ultrasonographic biomarkers to provide more objective evidence of treatment effect.

Why it matters

Potential benefit: If successful, ESWT could provide a noninvasive way to reduce wrist spasticity and improve comfort and function for chronic stroke survivors.

How similar studies have gone: Small trials and case series have reported reductions in post-stroke spasticity with ESWT, but larger, ultrasound-supported randomized data are limited so the approach is promising but not yet definitively proven.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 35 and 65 years.
* First-ever stroke episode confirmed by MRI and/or CT scan.
* Clinical diagnosis of hemiplegia.
* More than 6 months post-stroke.
* A Modified Ashworth Scale (MAS) score between 1 and 3 for wrist flexor spasticity.

Exclusion Criteria:

* History of more than one stroke episode
* Stroke onset more than ten years ago
* Stroke onset less than 6 months ago
* Age over 65 (to limit the effects of aging on muscle structure)
* Contraindications for ESWT (e.g., cancer, local tumor or active infection in the treatment area, pregnancy, coagulation disorders, pacemaker or other electronic/metallic implants)
* Severe aphasia or serious communication problems
* Presence of fixed contracture in the wrist
* Patients who have received botulinum toxin or phenol nerve block injections within the last 6 months
* Medically unstable patients (e.g., uncontrolled hypertension, diabetes mellitus, or severe cardiac, hepatic, or renal disease)

Where it's running

  • Pamukkale University
    Denizli, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.